A Phase 2 interventional study of solrikitug in COPD

Active, Not Recruiting Phase 2 NCT06496620

Study Description

A study to evaluate the safety and effectiveness of solrikitug in adults with chronic obstructive pulmonary disease (COPD)

Study Details

Registry ID:
NCT06496620
Conditions:
COPD
Phase:
Phase 2
Target Enrollment:
182 participants
Start Date:
Age Range:
40–75 years
Healthy Volunteers:
No

Study Locations (210 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →